Modern aspects of pathogenetic endometriosis therapy

In: HEALTH OF WOMAN · 2017 · pp. 101–108 · doi:10.15574/hw.2017.117.101 · W3100075358
article OA: diamond CC0

Abstract

The objective: to optimize treatment of endometriosis using a combined hormonal Luvyna medicine. Materials and methods. The study included 50 patients 22-36 years old with a diagnosis of endometriosis. In line with the patient’s therapy are divided into groups: I group (n = 25) received the Luvyna on a continuous 63/7 scheme, then 3 months in scheme 21/7; group II (n = 25) after surgical treatment of endometriosis (gistero-, laparoscopy) also received the medicine in a similar way. The mode of menstrual function disorders, pain on a visual rating scale of pain, psycho-emotional status, concomitant dysfunction of adjacent organs were evaluated. Results. According to the results of therapy established algodismenorei reduction in symptoms I group – 80%, II – 83%, abnormal uterine bleeding I – 96%, II – 100%; the disappearance of heavy uterine bleeding, improving the function of adjacent organs, psycho-emotional status in both groups. Reduced pain on a pain scale from 8±2.0 to 2±0.5 in the group I and from 7±2.5 to 1±1.0 in the group II. Conclusion. Luvina is a highly effective medicine for the treatment of endometriosis, comparable to the combined treatment - surgery, followed by the appointment of combined oral contraceptives. Recommended mode 63/7, followed by a reception 21/7, including after surgical treatment. Key words: endometriosis, Luvyna, conservative therapy, combined therapy.
Full text 5,310 characters · extracted from oa-html · 2 sections · click to expand

Materials

and methods. The study included 50 patients 22-36 years old with a diagnosis of endometriosis. In line with the patient’s therapy are divided into groups: I group (n = 25) received the Luvyna on a continuous 63/7 scheme, then 3 months in scheme 21/7; group II (n = 25) after surgical treatment of endometriosis (gistero-, laparoscopy) also received the medicine in a similar way. The mode of menstrual function disorders, pain on a visual rating scale of pain, psycho-emotional status, concomitant dysfunction of adjacent organs were evaluated. Results. According to the results of therapy established algodismenorei reduction in symptoms I group – 80%, II – 83%, abnormal uterine bleeding I – 96%, II – 100%; the disappearance of heavy uterine bleeding, improving the function of adjacent organs, psycho-emotional status in both groups. Reduced pain on a pain scale from 8±2.0 to 2±0.5 in the group I and from 7±2.5 to 1±1.0 in the group II. Conclusion. Luvina is a highly effective medicine for the treatment of endometriosis, comparable to the combined treatment – surgery, followed by the appointment of combined oral contraceptives. Recommended mode 63/7, followed by a reception 21/7, including after surgical treatment. Key words: endometriosis, Luvyna, conservative therapy, combined therapy.

References

1. Taktika vedennya patsientok z endometriozom. Adaptovana klinichna nastanova. K. 2016:118. 2. Unifikovaniy klinichniy protokol pervinnoyi, vtorinnoyi (spetsializovanoyi) ta tretinnoyi (visokospetsializovanoyi) medichnoyi dopomogi «Taktika vedennya patsientok z genitalnim endometriozom»/ Nakaz MOZ Ukrayini № 319 vid 06.04.2016. 3. Gerasimov AM. 2007. Prichinyi besplodiya pri naruzhnom endometrioze. Probl. reprod. 3:66–69. 4. Marzhevskaya AM, Rischuk SV, Gusev SN, Tatarova NA i soavt. 2014. Reproduktivnyie narusheniya u bolnyih endometriozom: etiologiya, patogenez, vozmozhnosti korrektsii. Byulleten Orenburg nauchnogo tsentra Uro RAN (elektronnyiy zhurnal). 3:1–42. 5. Ozhiganova IN. 2014. Morfologiya raka yaichnikov v klassifikatsii VOZ 2013 goda. Prakticheskaya onkologiya 15;4:143–152. 6. Prilepskaya VN, Ivanova EV, Tagieva AV, Letunovskaya AB. 2012. Endometrioz: ot trudnostey diagnostiki k novyim vozmozhnostyam terapii. Consilium Medicum. 4:4–8. 7. Prilepskaya VN. 2010. Endometrioz i reproduktivnoe zdorove zhenschin. Akusherstvo, ginekologiya i reproduktsiya 4;3. 8. Unanyan AL. 2010. Endometrioz i reproduktivnoe zdorove zhenschin. Akusherstvo, ginekologiya, reproduktologiya 4;3:6–11. 9. Serebrennikova KG, Kuznetsova EP, Lapshihin AA, Ivanova TV, Hmelevskaya VF i soavt. 2012. Reabilitatsiya reproduktivnoy funktsii zhenschin posle operativnogo lecheniya na yaichnikah. Mediko-sotsialnaya ekspertiza i reabilitatsiya 1:18–22. 10. Sahautdinova IV, Mustafina GT, Habibullina RN, Yarkina EI i soavt. 2015. Sovremennyie metodyi diagnostiki i lecheniya endometrioza yaichnikov. Meditsinskiy vestnik Bashkortostana 10;1:113–115. 11. Bulun SE. 2009. Endometriosis. N EnglJ Med 360:268–79. https://doi.org/10.1056/NEJMra080469; PMid:19144942 12. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E. 2005. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20:2698–2704. https://doi.org/10.1093/humrep/dei135; PMid:15980014 13. Meuleman C, Hoor AD, Van Cleynenbreugel B, Tomassetti S, Hoogh TD. 2011. Why we need international agreement on terms and definitions to assess clinical outcome after endometriosis surgery. Hum Reprod. 26(6):1598–1599. https://doi.org/10.1093/humrep/der098; PMid:21478183 14. Nnoaham K, Hummelshoj L, Webster P, D’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT. 2011. World Endometriosis Research Foundation Global Study of Women. Impact of endometriosis on quality of life and work productivity: A multi-centre study across 10 countries. Fertil Steril. 96:366–373. https://doi.org/10.1016/j.fertnstert.2011.05.090; PMid:21718982 PMCid:PMC3679489 15. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T et al. 2012. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 27:1292–1299. https://doi.org/10.1093/humrep/des073; PMid:22422778 16. Strowitzki et all. 2010. Dienogest in the treatment of endometriosis-associated pelvic pain: A 12-week, randomized, double-blind, placebocontrolled study. Eur J Obstet Gynecol Reprod Biol. 151(2):193–198. 17. Tomassetti C, Meuleman C, Pexsters A. 2006. Endometriosis recurrent miscarriage and implantation failure: is there an immunologial link? Reprod. Biomed. Online. 13;1:58–64. https://doi.org/10.1016/S1472-6483(10)62016-0 18. Endometriosis: Diagnosis and Management. JOGC. 2010:1–27.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK